Beranda › Limfoma Burkitt › Georgia › Atlanta
Uji klinis Limfoma Burkitt di Atlanta, GA
12 studi untuk Limfoma Burkitt mencari peserta di lokasi sekitar Atlanta (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
Menerima pesertaFase 2
- Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
Menerima pesertaFase 3
- Emory University Hospital/Winship Cancer Institute, Atlanta
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Menerima pesertaStudi observasional
- Children's Healthcare of Atlanta - Arthur M. Blank Hospital, Atlanta
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
Menerima pesertaFase 2
- Emory University Hospital/Winship Cancer Institute, Atlanta
- Emory Saint Joseph's Hospital, Atlanta
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
Menerima pesertaFase 2
- Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)
Menerima pesertaFase 1
- Winship Cancer Institute Emory University, Atlanta
- Northside Hospital Cancer Institute, Atlanta
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
Menerima pesertaFase 2
- Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
Menerima pesertaFase 3
- Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
Menerima pesertaFase 1/2
- Research Site, Atlanta
Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
Menerima pesertaFase 2
- Children's Healthcare of Atlanta at Egleston, Atlanta
Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL
Menerima pesertaFase 1
- Winship Cancer Institute, Emory University, Atlanta
The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL
Menerima pesertaFase 2
- Children's Healthcare of Atlanta, Atlanta
Uji klinis Limfoma Burkitt di kota lain
- Houston, TX21 studi
- Philadelphia, PA16 studi
- Milwaukee, WI16 studi
- Chicago, IL15 studi
- New York City, NY13 studi
- Cincinnati, OH13 studi
- Aurora, CO11 studi
- Seattle, WA11 studi
- Durham, NC10 studi
- Boston, MA10 studi
- Kansas City, MO10 studi
- Los Angeles, CA10 studi
Studi lain di Atlanta
- Kanker (semua jenis)49 studi
- Kanker Paru Non-Sel Kecil47 studi
- Mieloma Multipel42 studi
- Kanker Payudara41 studi
- Kanker Prostat33 studi
- Leukemia Mieloid Akut31 studi
- Kanker Ovarium29 studi
- Kanker Kolorektal29 studi
- Kanker Paru29 studi
- Kanker Metastatik28 studi
- Gangguan Depresi Mayor25 studi
- Gagal Jantung25 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.